Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002594688 | SCV002956415 | pathogenic | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser1117Lysfs*3) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 1919174). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003464573 | SCV004195302 | likely pathogenic | Retinitis pigmentosa 25 | 2023-04-26 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV003464573 | SCV005091007 | likely pathogenic | Retinitis pigmentosa 25 | 2023-05-17 | criteria provided, single submitter | clinical testing | PVS1, PM2 - It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446) |
Fulgent Genetics, |
RCV003464573 | SCV005670619 | likely pathogenic | Retinitis pigmentosa 25 | 2024-02-27 | criteria provided, single submitter | clinical testing |